HEALTH CARE RESOURCE USE OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY IN SWEDEN

被引：0
|
作者：
Lauppe, R. [1 ]
Hansen, Liseth J. [1 ]
Fornwall, A. [1 ]
Gerdeskold, C. [2 ]
Rozenbaum, M. [3 ]
Strand, A. [4 ]
Vakevainen, M. [5 ]
Kuusisto, J. [6 ,7 ]
Gude, E. [8 ]
Gustafsson, F. [9 ]
Smith, J. G. [10 ]
机构：
[1] Quantify Res, Stockholm, Sweden
[2] Pfizer Innovat AB, Stockholm, Sweden
[3] Pfizer Inc, Capelle Aan Den Ijssel, Netherlands
[4] Pfizer ApS, Ballerup 84, Denmark
[5] Pfizer Oy, Helsinki, Finland
[6] Univ Eastern Finland, Kuopio, Finland
[7] Kuopio Univ Hosp, Kuopio, Finland
[8] Oslo Univ Hosp, Rikshosp, Oslo, Norway
[9] Rigshosp, Copenhagen, Denmark
[10] Lund Univ, Lund, Sweden
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSB112
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [31] Cerebrovascular Involvement in Transthyretin Amyloid Cardiomyopathy
    Haider, Lukas
    Schrutka, Lore
    Tommasino, Emanuele
    Avanzini, Nicolas
    Hauck, Sven
    Nowak, Nikolaus
    Hengstenberg, Christian
    Bonderman, Diana
    Thurnher, Majda
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [32] Sex Differences in Transthyretin Amyloid Cardiomyopathy
    Jefferson, Artrish
    Vaishnav, Joban
    Sharma, Kavita
    Gilotra, Nisha A.
    Polydefkis, Michael
    Ranek, Mark J.
    Hubbard, Abby
    Yanek, Lisa
    Shankar, Bairavi
    CIRCULATION, 2023, 148
  • [33] Tafamidis for Transthyretin Amyloid Cardiomyopathy Reply
    Maurer, Mathew S.
    Sultan, Marla B.
    Rapezzi, Claudio
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (02): : 196 - 197
  • [34] Clinical characteristics and health care resource use of patients at risk for wild-type transthyretin amyloid cardiomyopathy identified by machine learning model (vol 29, pg 530, 2023)
    Bruno, M.
    Sheer, R.
    Reed, C.
    Schepart, A.
    Nair, R.
    Simmons, J. D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (07): : 769 - 769
  • [35] Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy
    Garcia-Pavia, Pablo
    Damy, Thibaud
    Piriou, Nicolas
    Barriales-Villa, Roberto
    Cappelli, Francesco
    Bahus, Catherine
    Munteanu, Carmen
    Keohane, Denis
    Mallaina, Pablo
    Elliott, Perry
    ESC HEART FAILURE, 2024, 11 (06): : 4314 - 4324
  • [36] Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
    Morfino, Paolo
    Aimo, Alberto
    Vergaro, Giuseppe
    Sanguinetti, Chiara
    Castiglione, Vincenzo
    Franzini, Maria
    Perrone, Marco Alfonso
    Emdin, Michele
    PHARMACEUTICS, 2023, 15 (04)
  • [37] Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function
    Nakano, Tomoya
    Onoue, Kenji
    Terada, Chiyoko
    Terasaki, Satoshi
    Ishihara, Satomi
    Hashimoto, Yukihiro
    Nakada, Yasuki
    Nakagawa, Hitoshi
    Ueda, Tomoya
    Seno, Ayako
    Nishida, Taku
    Watanabe, Makoto
    Hoshii, Yoshinobu
    Hatakeyama, Kinta
    Sakaguchi, Yasuhiro
    Ohbayashi, Chiho
    Saito, Yoshihiko
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [38] Prognostic implications of health-related quality of life in transthyretin amyloid cardiomyopathy
    Poledniczek, Michael
    Kronberger, Christina
    Willixhofer, Robin
    Ermolaev, Nikita
    Cherouny, Bernhard
    Dachs, Theresa-Marie
    Rettl, Rene
    Binder-Rodriguez, Christina
    Camuz-Ligios, Luciana
    Gregshammer, Bernhard
    Kammerlander, Andreas
    Kastner, Johannes
    Bergler-Klein, Jutta
    Duca, Franz
    Eslam, Roza Badr
    Kronberger, Christina
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [39] Health-related quality of life among transthyretin amyloid cardiomyopathy patients
    Eldhagen, Per
    Lehtonen, Jukka
    Gude, Einar
    Gustafsson, Finn
    Bagger-Bahnsen, Anne
    Vakevainen, Merja
    Pilgaard, Trine
    Wedell-Wedellsborg, Dorte
    Poulsen, Steen Hvitfeldt
    ESC HEART FAILURE, 2023, 10 (03): : 1871 - 1882
  • [40] Prognostic implications of health-related quality of life in transthyretin amyloid cardiomyopathy
    Poledniczek, M.
    Kronberger, C.
    Willixhofer, R.
    Ermolaev, N.
    Cherouny, B.
    Dachs, T.
    Rettl, R.
    Binder-Rodriguez, C.
    Camuz, Ligios L.
    Gregshammer, B.
    Kammerlander, A.
    Kastner, J.
    Bergler-Klein, J.
    Duca, F.
    Badr, Eslam R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S387 - S387
12345